TTA-Q6 - CAS 910484-28-5

TTA-Q6, a selective T-type Ca2+ channel antagonist, exhibits potential antitumor and immunomodulatory activities for treating neurological disorders by inhibiting the uptake of extracellular calcium ions by tumor cells, thereby inducing intracellular calcium deficiency and endoplasmic reticulum (ER) stress.

Calcium Channel

Membrane transporter/Ion channel, Metabolism

910451

0.9997

C20H15ClF3N3O

405.8

FC(F)(F)CN1C(=O)Nc2ccc(Cl)cc2[C@]1(C1CC1)c1ccc(cc1)C#N

-20°C

Ice Packs

Small Compound